Bitcoin, originally designed for peer-to-peer payments, is increasingly valued as a store of wealth rather than a medium for daily transactions. Its price depends on limited supply and investment demand, not transaction volume. The introduction of Bitcoin ETFs offers new investment channels, boosting demand without requiring payment use. However, low transaction activity could challenge network security funding in the long term, as miners rely on fees alongside block rewards. Technologies like the Lightning Network may help maintain payment functionality without burdening the main blockchain.
Bitcoin's evolving role as a store of value rather than a payment method is context for cryptocurrency market activity. For readers following crypto broadly, here is Pluang's market snapshot as of Oct 14, 2026 02:03 WIB: out of 50 major cryptocurrencies, 19 rose and 30 fell today. Tezos (XTZ) gained 4.54% to Rp5.779, Filecoin (FIL) rose 4.34% to Rp21.063, while COTI (COTI) declined 4.45% to Rp224.
Domino's Pizza reported Q3 2026 earnings per share of $4.60, beating analyst expectations of $4.37, while revenue grew modestly by 3.4% to $1.19 billion. Same-store sales growth was minimal at 0.3% in the U.S. and 0.2% internationally, reflecting com...
Citigroup reported Q3 2026 earnings that exceeded analyst expectations, with EPS of $2.85 beating the $2.65 estimate and revenue of $23.8 billion slightly above forecasts. The bank's profit rose 40%, driven by exceptional fixed-income trading, invest...
State Street is set to report its Q3 2026 earnings with forecasts showing a 31.3% increase in earnings and 14% revenue growth, driven by strong net interest income and service fees. Despite record assets under management, higher operating and technol...
Restaurant Technologies, Inc. (RTI) released its 2026 Impact Report highlighting significant progress in sustainability and operational efficiency. In 2025, RTI recycled 393 million pounds of used cooking oil and delivered 719.4 million pounds of fre...
Over 60 companies are actively developing more than 65 medical marijuana therapies targeting conditions like chronic pain, neurological disorders, and cancer symptoms. Key drugs such as ZYN-002 and CardiolRx are in late-stage trials, with others in e...
